Cancer Family
Malignant Skin Neoplasm
CI-CAN-00000250Explore in graph →
320 active trials14 approved drugs64 evidence items
- NCIt
- C2920
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000250Explore in graph →
Clinical trials
1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (202)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06577311 | Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis) | unknown | Phase 2 | 20 | The Center for Clinical and Cosmetic ResearchOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT06536946 | B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers | unknown | — | 50 | Sohag UniversityOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06476964 | Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics(StratiKA) | unknown | N/A | 200 | University Hospital, BordeauxOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT05955443 | iToBoS Prospective Data Acquisition and Feasibility Study (Barcelona)(iToBoS BCN) | unknown | — | 350 | The University of QueenslandOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05246163 | ARTIficial Intelligence-based Smartphone Application for Skin Cancer Detection(ARTIS) | unknown | — | 2,500 | University Hospital, GhentOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT06421571 | The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients(GR-CTCL_CL) | unknown | — | 40 | National and Kapodistrian University of AthensOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06409195 | A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers | unknown | Phase 2 | 50 | DermBiont, Inc.INDUSTRY | 1 | May 10, 2024 | clinicaltrials |
| NCT04745234 | Mogamulizumab Q4week Dosing in Participants With R/R CTCL | unknown | Phase 2 | 34 | Kyowa Kirin, Inc.INDUSTRY | 5 | Apr 25, 2024 | clinicaltrials |
| NCT06342297 | Dermatoscopy Guided Resection for Skin Cancer | unknown | N/A | 400 | Region Örebro CountyOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06299878 | MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns](CRISTINA) | unknown | — | 72 | Russian Academy of Medical SciencesOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06271603 | Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas(ECOBASO) | unknown | N/A | 704 | Damae MedicalINDUSTRY | 1 | Feb 22, 2024 | clinicaltrials |
| NCT05904522 | Histopathological Changes in Mycosis Fungoides | unknown | N/A | 10 | Bezmialem Vakif UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT06254547 | Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App | unknown | N/A | 150 | Herlev HospitalOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT06227416 | Skin Tumor Biomarkers by Mass Spectrometry Imaging | unknown | N/A | 300 | Bispebjerg HospitalOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT06145464 | Shadow for All, a Citizenship Science Study to Promote the Prevention of Skin Cancer(Shadow4All) | unknown | N/A | 60 | Universidade do PortoOTHER | 0 | Jan 17, 2024 | clinicaltrials |
| NCT06150144 | The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma | unknown | Phase 3 | 40 | University of AleppoOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT04485442 | Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face | unknown | — | 100 | University Hospital, Basel, SwitzerlandOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT05490485 | Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma | unknown | Phase 2 | 20 | Henan Cancer HospitalOTHER_GOV | 1 | Nov 8, 2023 | clinicaltrials |
| NCT06080711 | AI-Augmented Skin Cancer Diagnosis in Teledermatoscopy(AIDMel) | unknown | N/A | 30 | Karolinska University HospitalOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT04362722 | Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients(DUNCAN) | unknown | Phase 2 | 40 | Philogen S.p.A.INDUSTRY | 3 | Oct 10, 2023 | clinicaltrials |
| NCT05329792 | L19IL2/L19TNF in Skin Cancer Patients(IntriNSiC) | unknown | Phase 2 | 70 | Philogen S.p.A.INDUSTRY | 3 | Oct 6, 2023 | clinicaltrials |
| NCT05781386 | A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors | unknown | Phase 1 | 255 | Jiangsu Simcere Biologics Co., LtdINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06037239 | Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study | unknown | Phase 1 / Phase 2 | 53 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT05932511 | Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer | unknown | Early Phase 1 | 15 | Center for Biomedical Research, Inc.INDUSTRY | 1 | Aug 30, 2023 | clinicaltrials |
| NCT05845632 | Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma | unknown | — | 965 | Maastricht University Medical CenterOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT05886140 | Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin | unknown | N/A | 24 | Henan Cancer HospitalOTHER_GOV | 1 | Aug 8, 2023 | clinicaltrials |
| NCT03982212 | A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors | unknown | Phase 1 | 10 | University of Kansas Medical CenterOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05855460 | Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study | unknown | — | 20 | Cairo UniversityOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT03769285 | Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial(SPRINTR-Pilot) | unknown | Phase 2 | 120 | Women's College HospitalOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05170035 | Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery | unknown | N/A | 26 | Bispebjerg HospitalOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT05429866 | Immunological Variables Associated to ICI Toxicity in Cancer Patients | unknown | Phase 2 | 441 | Jules Bordet InstituteOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05526638 | Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides | unknown | N/A | 15 | Cairo UniversityOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT03775525 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer(GEN602) | unknown | Phase 1 | 127 | Genzada Pharmaceuticals USA, Inc.INDUSTRY | 1 | Dec 23, 2022 | clinicaltrials |
| NCT05602792 | A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 233 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04118868 | Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma. | unknown | Phase 1 | 10 | Sorrento Therapeutics, Inc.INDUSTRY | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05569057 | A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma | unknown | Phase 1 | 100 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Oct 7, 2022 | clinicaltrials |
| NCT05550766 | Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma | unknown | — | 50 | Sohag UniversityOTHER | 0 | Sep 22, 2022 | clinicaltrials |
| NCT05238363 | The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) | unknown | Phase 2 | 20 | Shanghai Henlius BiotechINDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05414162 | Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy | unknown | — | 60 | University Hospital, BonnOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02437279 | Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients(OpACIN) | unknown | Phase 1 | 20 | The Netherlands Cancer InstituteOTHER | 1 | Apr 15, 2022 | clinicaltrials |
| NCT04491825 | Diagnostic Classifier for Cutaneous T-cell Lymphomas | unknown | — | 160 | Medical University of ViennaOTHER | 1 | Apr 5, 2022 | clinicaltrials |
| NCT04664582 | Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck | unknown | N/A | 100 | Jewish General HospitalOTHER | 1 | Apr 5, 2022 | clinicaltrials |
| NCT05246228 | Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy(HR-cSCC) | unknown | — | 42 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 0 | Feb 18, 2022 | clinicaltrials |
| NCT05136079 | Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous Malignancies(LYMbR) | unknown | Phase 3 | 40 | Alberta Health Services, CalgaryOTHER | 1 | Nov 26, 2021 | clinicaltrials |
| NCT03291002 | Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC | unknown | Phase 1 | 98 | CureVacINDUSTRY | 5 | Nov 4, 2021 | clinicaltrials |
| NCT02242929 | Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma(SCIN) | unknown | Phase 3 | 145 | Maastricht University Medical CenterOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT04968704 | Computer Modelling to Plan Surgical Reconstruction | unknown | — | 10 | Royal Free Hospital NHS Foundation TrustOTHER | 0 | Jul 20, 2021 | clinicaltrials |
| NCT04842279 | FACE-Q in Facial Reconstructive Surgery: A Prospective Database | unknown | — | 300 | McMaster UniversityOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT04805905 | A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study | unknown | — | 30 | McMaster UniversityOTHER | 0 | Mar 18, 2021 | clinicaltrials |
| NCT04625491 | Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor. | unknown | — | 300 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Feb 10, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Aug 29, 2024source: clinicaltrials